Literature DB >> 20303751

Conformationally-restricted amino acid analogues bearing a distal sulfonic acid show selective inhibition of system x(c)(-) over the vesicular glutamate transporter.

Jean-Louis G Etoga1, S Kaleem Ahmed, Sarjubhai Patel, Richard J Bridges, Charles M Thompson.   

Abstract

A panel of amino acid analogs and conformationally-restricted amino acids bearing a sulfonic acid were synthesized and tested for their ability to preferentially inhibit the obligate cysteine-glutamate transporter system x(c)(-) versus the vesicular glutamate transporter (VGLUT). Several promising candidate molecules were identified: R/S-4-[4'-carboxyphenyl]-phenylglycine, a biphenyl substituted analog of 4-carboxyphenylglycine and 2-thiopheneglycine-5-sulfonic acid both of which reduced glutamate uptake at system x(c)(-) by 70-75% while having modest to no effect on glutamate uptake at VGLUT. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20303751      PMCID: PMC2860375          DOI: 10.1016/j.bmcl.2009.10.020

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  27 in total

1.  Quinoline-2,4-dicarboxylic acids: synthesis and evaluation as inhibitors of the glutamate vesicular transport system.

Authors:  C N Carrigan; C S Esslinger; R D Bartlett; R J Bridges; C M Thompson
Journal:  Bioorg Med Chem Lett       Date:  1999-09-06       Impact factor: 2.823

Review 2.  The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes.

Authors:  Richard J Bridges; C Sean Esslinger
Journal:  Pharmacol Ther       Date:  2005-04-14       Impact factor: 12.310

3.  Glutamate uptake into synaptic vesicles--inhibition by sulphur amino acids.

Authors:  J Dunlop; A Fear; R Griffiths
Journal:  Neuroreport       Date:  1991-07       Impact factor: 1.837

4.  Synthesis and in vitro pharmacology of substituted quinoline-2,4-dicarboxylic acids as inhibitors of vesicular glutamate transport.

Authors:  Christina N Carrigan; Richard D Bartlett; C Sean Esslinger; Kimberly A Cybulski; Pakamas Tongcharoensirikul; Richard J Bridges; Charles M Thompson
Journal:  J Med Chem       Date:  2002-05-23       Impact factor: 7.446

5.  Differentiation of substrate and non-substrate inhibitors of transport system xc(-): an obligate exchanger of L-glutamate and L-cystine.

Authors:  Sarjubhai A Patel; Brady A Warren; Joseph F Rhoderick; Richard J Bridges
Journal:  Neuropharmacology       Date:  2004-02       Impact factor: 5.250

Review 6.  Inhibitor of the glutamate vesicular transporter (VGLUT).

Authors:  Charles M Thompson; Erin Davis; Christina N Carrigan; Holly D Cox; Richard J Bridges; John M Gerdes
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

Review 7.  [Pharmacology of excitatory amino acid transporters (EAATs and VGLUTs)].

Authors:  Yasushi Shigeri; Keiko Shimamoto
Journal:  Nihon Yakurigaku Zasshi       Date:  2003-09

Review 8.  Neuro-transmitters in the central nervous system & their implication in learning and memory processes.

Authors:  Helton J Reis; Cristina Guatimosim; Maryse Paquet; Magda Santos; Fabíola M Ribeiro; Arthur Kummer; Grace Schenatto; João V Salgado; Luciene B Vieira; Antônio L Teixeira; András Palotás
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

9.  Uptake of L-glutamate into synaptic vesicles: competitive inhibition by dyes with biphenyl and amino- and sulphonic acid-substituted naphthyl groups.

Authors:  S Roseth; E M Fykse; F Fonnum
Journal:  Biochem Pharmacol       Date:  1998-11-01       Impact factor: 5.858

10.  Substituted quinolines as inhibitors of L-glutamate transport into synaptic vesicles.

Authors:  R D Bartlett; C S Esslinger; C M Thompson; R J Bridges
Journal:  Neuropharmacology       Date:  1998-07       Impact factor: 5.250

View more
  10 in total

1.  System xc⁻ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS.

Authors:  Richard J Bridges; Nicholas R Natale; Sarjubhai A Patel
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

2.  Use of the hydantoin isostere to produce inhibitors showing selectivity toward the vesicular glutamate transporter versus the obligate exchange transporter system x(c)(-).

Authors:  S Kaleem Ahmed; Jean-Louis G Etoga; Sarjubhai A Patel; Richard J Bridges; Charles M Thompson
Journal:  Bioorg Med Chem Lett       Date:  2011-05-14       Impact factor: 2.823

Review 3.  Conformationally constrained histidines in the design of peptidomimetics: strategies for the χ-space control.

Authors:  Azzurra Stefanucci; Francesco Pinnen; Federica Feliciani; Ivana Cacciatore; Gino Lucente; Adriano Mollica
Journal:  Int J Mol Sci       Date:  2011-05-03       Impact factor: 5.923

4.  Microwave accelerated synthesis of isoxazole hydrazide inhibitors of the system xc- transporter: Initial homology model.

Authors:  Afnan A Matti; Joseph Mirzaei; John Rudolph; Stephen A Smith; Jayme L Newell; Sarjubhai A Patel; Michael R Braden; Richard J Bridges; Nicholas R Natale
Journal:  Bioorg Med Chem Lett       Date:  2013-08-27       Impact factor: 2.823

5.  The development of benzo- and naphtho-fused quinoline-2,4-dicarboxylic acids as vesicular glutamate transporter (VGLUT) inhibitors reveals a possible role for neuroactive steroids.

Authors:  Christina N Carrigan; Sarjubhai A Patel; Holly D Cox; Erin S Bolstad; John M Gerdes; Wesley E Smith; Richard J Bridges; Charles M Thompson
Journal:  Bioorg Med Chem Lett       Date:  2013-12-25       Impact factor: 2.823

Review 6.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Amantadine Combines Astroglial System Xc- Activation with Glutamate/NMDA Receptor Inhibition.

Authors:  Tomosuke Nakano; Toshiki Hasegawa; Dai Suzuki; Eishi Motomura; Motohiro Okada
Journal:  Biomolecules       Date:  2019-05-17

8.  Reducing the Kidney Uptake of High Contrast CXCR4 PET Imaging Agents via Linker Modifications.

Authors:  Daniel Kwon; Zhengxing Zhang; Jutta Zeisler; Hsiou-Ting Kuo; Kuo-Shyan Lin; Francois Benard
Journal:  Pharmaceutics       Date:  2022-07-20       Impact factor: 6.525

9.  High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells.

Authors:  Ajit G Thomas; Rita Sattler; Karen Tendyke; Kara A Loiacono; Hans Hansen; Vishal Sahni; Yutaka Hashizume; Camilo Rojas; Barbara S Slusher
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

Review 10.  Membrane Transporters and Channels in Melanoma.

Authors:  Ines Böhme; Roland Schönherr; Jürgen Eberle; Anja Katrin Bosserhoff
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.